Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is radiotherapy optimally combined with chemotherapy in elderly patients with limited-stage small-cell lung cancer?

Nature Clinical Practice Oncology volume 2, pages 550–551 (2005)Cite this article

boxed-textSchild SE et al. (2005) Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly. Cancer 103: 2349–2354

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Turrisi AT et al. (1999) Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340: 265–271

    Article  CAS  Google Scholar 

  2. Takada M et al. (2002) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group study 9104. J Clin Oncol 20: 3054–3060

    Article  CAS  Google Scholar 

  3. Schild SE et al. (2004) Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 59: 943–951

    Article  Google Scholar 

  4. Yuen AR et al. (2000) Similar outcome of elderly patients in Intergroup trial 0096: Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma. Cancer 89: 1953–1960

    Article  CAS  Google Scholar 

  5. Quon H et al. (1999) The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys 43: 39–45

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Deputy Director of the National Cancer Center Hospital East, Tokyo, Japan

    Nagahiro Saijo

Authors
  1. Nagahiro Saijo
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saijo, N. Is radiotherapy optimally combined with chemotherapy in elderly patients with limited-stage small-cell lung cancer?. Nat Rev Clin Oncol 2, 550–551 (2005). https://doi.org/10.1038/ncponc0328

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0328

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing